---
date: October 16, 2020
excerpt: Drugs and medications
layout: post
redirect_from:
- /medications/does-remdesivir-benefit-patients-with-covid-19/
sources:
- agency: fda
  url: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/coronavirus-disease-2019-covid-19-frequently-asked-questions#5ebcd92778fc0
title: Does (Veklury) remdesivir benefit patients with COVID-19?
---

The safety and efficacy of Veklury (remdesivir) for the treatment of COVID-19 are being evaluated in multiple ongoing clinical trials. Data from multiple phase 3 clinical trials suggest that Veklury (remdesivir) might benefit patients with COVID-19.